BE891679A - Compositions de plasmine stabilisee et leur procede de preparation - Google Patents

Compositions de plasmine stabilisee et leur procede de preparation

Info

Publication number
BE891679A
BE891679A BE6/47574A BE6047574A BE891679A BE 891679 A BE891679 A BE 891679A BE 6/47574 A BE6/47574 A BE 6/47574A BE 6047574 A BE6047574 A BE 6047574A BE 891679 A BE891679 A BE 891679A
Authority
BE
Belgium
Prior art keywords
preparation
plasmin compositions
stabilized
stabilized plasmin
compositions
Prior art date
Application number
BE6/47574A
Other languages
English (en)
Inventor
A Diedrichen
M Johannessen
P Tang
Original Assignee
Novo Industri As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Industri As filed Critical Novo Industri As
Publication of BE891679A publication Critical patent/BE891679A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6435—Plasmin (3.4.21.7), i.e. fibrinolysin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BE6/47574A 1981-01-05 1982-01-04 Compositions de plasmine stabilisee et leur procede de preparation BE891679A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8100133 1981-01-05

Publications (1)

Publication Number Publication Date
BE891679A true BE891679A (fr) 1982-07-05

Family

ID=10518790

Family Applications (1)

Application Number Title Priority Date Filing Date
BE6/47574A BE891679A (fr) 1981-01-05 1982-01-04 Compositions de plasmine stabilisee et leur procede de preparation

Country Status (8)

Country Link
US (1) US4462980A (fr)
BE (1) BE891679A (fr)
CH (1) CH648862A5 (fr)
DE (1) DE3200058A1 (fr)
DK (1) DK982A (fr)
FR (1) FR2500755A1 (fr)
IT (1) IT1194135B (fr)
NL (1) NL8200004A (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816568A (en) * 1986-05-16 1989-03-28 International Minerals & Chemical Corp. Stabilization of growth hormones
US5288489A (en) * 1991-08-28 1994-02-22 Orion Therapeutic Systems, Inc. Fibrinolysis and fibrinogenolysis treatment
US6355243B1 (en) * 1999-11-13 2002-03-12 Bayer Corporation Method of thrombolysis by local delivery of active plasmin
US6964764B2 (en) * 1999-11-13 2005-11-15 Talecris Biotherapeutics, Inc. Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
US6969515B2 (en) 1999-11-13 2005-11-29 Talecris Biotherapeutics, Inc. Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
US7544500B2 (en) * 1999-11-13 2009-06-09 Talecris Biotherapeutics, Inc. Process for the production of a reversibly inactive acidified plasmin composition
CA2426543C (fr) 2000-11-28 2007-09-18 David M. Waisman Polypeptides anti-angiogeniques
US20040142897A1 (en) * 2001-11-28 2004-07-22 Waisman David M. Compositions and methods for inhibiting tumor growth and metastasis
US7250271B2 (en) * 2001-11-28 2007-07-31 David Waisman Anti-angiogenesis methods, compositions and uses therefor
GB0228409D0 (en) 2002-12-06 2003-01-08 Thromb X Nv Pharmacological vitreolysis
AU2003297181A1 (en) 2002-12-13 2004-07-09 Mediomics, Llc Compositions and methods for inhibiting tumor growth and metastasis
WO2006134822A1 (fr) * 2005-06-14 2006-12-21 Nihon Medi-Physics Co., Ltd. Agent d’imagerie pour diagnostic radioactif
CA2726908C (fr) * 2008-06-04 2017-01-24 Talecris Biotherapeutics, Inc. Composition, methode et necessaire pour la preparation de plasmine
PL2403865T3 (pl) 2009-03-03 2016-01-29 Grifols Therapeutics Inc Sposoby wytwarzania plazminogenu
NZ597452A (en) 2009-07-10 2013-10-25 Thrombogenics Nv Variants of plasminogen and plasmin
EP2661493B1 (fr) 2011-01-05 2016-03-30 ThromboGenics N.V. Variantes de plasminogène et de plasmine
JP6000353B2 (ja) 2011-08-12 2016-09-28 スロンボジェニックス・ナムローゼ・フェンノートシャップＴｈｒｏｍｂｏＧｅｎｉｃｓ ＮＶ プラスミノーゲンおよびプラスミンの変異体

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950513A (en) * 1965-12-03 1976-04-13 Novo Terapeutisk Laboratorium A/S Process of stabilizing therapeutically useful plasmin solutions
US3720761A (en) * 1968-10-14 1973-03-13 W Hunter Injectable radio-pharmaceutical scanning agent and preparation
US3863004A (en) * 1972-03-20 1975-01-28 Mallinckrodt Chemical Works Denatured macroprotein with divalent tin for tagging with technetium-99m and method of preparation
US4062933A (en) * 1975-05-27 1977-12-13 Mallinckrodt, Inc. Colloidal compositions with protective agents suitable for radioactive labeling
US4048296A (en) * 1975-05-27 1977-09-13 Mallinckrodt, Inc. Radiopharmaceutical scanning agents
DE2916711A1 (de) * 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
US4462980A (en) 1984-07-31
IT8125932A0 (it) 1981-12-31
FR2500755B1 (fr) 1984-01-13
DE3200058A1 (de) 1982-11-04
IT1194135B (it) 1988-09-14
CH648862A5 (de) 1985-04-15
DK982A (da) 1982-07-06
FR2500755A1 (fr) 1982-09-03
NL8200004A (nl) 1982-08-02

Similar Documents

Publication Publication Date Title
FI822605A0 (fi) Apparat foer tillverkning av glaskaerl
FI831405A0 (fi) Kirurgiskt klamringssystem och apparat
BE891679A (fr) Compositions de plasmine stabilisee et leur procede de preparation
IT1194394B (it) Cefem-derivati e procedimenti per la loro preparazione
FI821444A0 (fi) Apparat foer maetning av bandmaterials tjockleksprofil
FI821812A0 (fi) Foerfarande och apparat foer maetning av dryckkoncentrat
FR2497207B1 (fr) Composition antigingivite, son procede de preparation et son application
BE893707R (fr) Azabicyclohexanes et procede de leur preparation
FR2517788B1 (fr) Joints et procede de leur preparation
DK173581A (da) Kunstfjer til badmintonbolde
BE889049A (fr) Nouvelles quinoxaline-2-yl-ethenylcetones et leur procede de preparation
AT388068B (de) Horizontalablenkschaltung
GB2090599B (en) Stabilized plasmin compositions and method for preparation thereof
FR2518091B1 (fr) 23-dehydro-25-hydroxyvitamine d3, son procede de preparation et composition pharmaceutique la renfermant
PH16694A (en) Platinum compounds and pharmaceutical composition thereof
FI830379A0 (fi) Kompositioner och metoder foer reducering av vaextskador
BR8204915A (pt) Composicao estabilizada
IT8224456A0 (it) Prostacicline e procedimento per laloro preparazione
IT1208432B (it) Composizioni farmaceutiche
IT8249072A0 (it) Composizioni farmaceutiche
FR2534917B1 (fr) Epoxycarbacyclines, leur procede de preparation et leur application
BE893809A (fr) Savons metalliques granulaires et leur preparation
FR2503711B1 (fr) Derives de cepheme et procede pour leur preparation
FR2573073B1 (fr) Derives allylbenzyliques et procedes pour leur preparation
IT1197433B (it) Composizioni antibatteriche e anticoccidiche e procedimento per la loro preparazione

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: NOVO INDUSTRI A/S

Effective date: 19890131